2009 45th ASCO Annual Meeting - účast ČR

Adjuvant Therapy

Oral vinorelbine (NVBo) and anastrozole (A) as neoadjuvant treatment of locally advanced (LA) breast cancer (BC) in hormone receptor positive (HR+) postmenopausal patients: Results of an international phase II trial

Autoři: Marcello Riggi; E. M. Moreno-Lopez; J. Rolski; P. Petruzelka; Jean Marc Ferrero; E. Tellez-Bernal; Nathalie Vaissiere; C. Lucas
Číslo abstraktu: 600
Kategorie: Zhoubné nádory prsu

Pharmacogenomic prediction of breast cancer treatment outcome with adjuvant tamoxifen in postmenopausal women with estrogen receptor-positive breast cancer

Autoři: MUDr. Olga Přibylová, PhD.; prof. MUDr. Luboš Petruželka, CSc.; MUDr. Soňa Argalacsová; doc. MUDr. Bohuslav Konopásek, CSc.; J. Drazdakova; Doc. MUDr. Ondřej Slanař, Ph.D.; prof. MUDr. Tomáš Zima, DrSc., MBA
Číslo abstraktu: e11501
Kategorie: Zhoubné nádory prsu

Central Nervous System Tumors

Scoring systems predictive of survival and local control of patients irradiated for brain metastases

Autoři: L. Dziggel; T. Veninga; T. Haatanen; doc. MUDr. Radka Lohynská, Ph.D.; S. E. Schild; D. Rades
Číslo abstraktu: 2075
Kategorie: zhoubné nádory mozku a CNS

Kidney Cancer

Final results of the phase III, randomized, double-blind AVOREN trial of first-line bevacizumab (BEV) + interferon-á2a (IFN) in metastatic renal cell carcinoma (mRCC)

Autoři: MD Bernard J. Escudier; MD Joaquim Bellmunt; S.N. Negrier; prof. MUDr. Bohuslav Melichar, Ph.D.; Sergio Bracarda; Prof. MD Alain Ravaud, PhD; S. Golding; S. Jethwa
Číslo abstraktu: 5020
Kategorie: Genitourinární nádory

Leukemia

Clinical improvement with a novel CD20 mAb, ofatumumab, in fludarabine-refractory chronic lymphocytic leukemia (CLL) also refractory to alemtuzumab or with bulky lymphadenopathy

Autoři: MD Thomas J. Kipps, PhD; A. C. Osterborg; prof. MUDr. Jiří Mayer, CSc.; MD Stephan Stilgenbauer; MD Andrzej Hellmann, Ph.D.; Catherine D. Williams, MBBS, MRCP, FRCPath; Richard R. Furman; MD Geoffrey (W.) Chan; Charlotte A Russell ; MD William G. Wierda, PhD
Číslo abstraktu: 7043
Kategorie: Maligní lymfomy a leukémie

Activity of ofatumumab, a novel CD20 mAb, and prior rituximab exposure in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia (CLL)

Autoři: MD William G. Wierda, PhD; MD Thomas J. Kipps, PhD; prof. MUDr. Jiří Mayer, CSc.; MD Stephan Stilgenbauer; MD Tadeusz Robak, PhD.; Catherine D. Williams, MBBS, MRCP, FRCPath; Richard R. Furman; MD Geoffrey (W.) Chan; Charlotte A Russell ; A. C. Osterborg
Číslo abstraktu: 7044
Kategorie: Maligní lymfomy a leukémie

Lymphoma

R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study

Autoři: MD Christian Gisselbrecht; M.D. Bertram Glass, PhD; N. Mounier; Devinder S Gill, MB ChB, MRCP (UK), FRCPath (Lond); David Linch, FMedSci; Prof. MUDr. Marek Trněný, CSc.; MD Andre Bosly, PhD; MD Ofer Shpilberg, MPH; Nicolas Ketterer; M.D. Craig H Moskowitz; MD Norbert Schmitz
Číslo abstraktu: 8509
Kategorie: Maligní lymfomy a leukémie

Eight cycles of BEACOPP escalated compared with 4 cycles of BEACOPP escalated followed by 4 cycles of BEACOPP baseline with or without radiotherapy in patients in advanced stage Hodgkin lymphoma (HL): Final analysis of the HD12 trial of the German Ho

Autoři: MD Volker Diehl; Heinz Haverkamp; Rolf Peter Mueller; Hans Konrad Mueller-Hermelink; Thomas Cerny; MUDr. Jana Marková; Prof.MD Anthony D. Ho, PhD, FRCP; MD Lothar Kanz; MD Richard Greil, Ph.D.; Prof. MD Andreas Engert
Číslo abstraktu: 8544
Kategorie: Maligní lymfomy a leukémie

Metastatic Breast Cancer

Tumor phenotype and characteristics of metastatic brain involvement in breast cancer patients: Potential clinical consequences

Autoři: MUDr. Markéta Palácová; prof. MUDr. Marek Svoboda, Ph.D.; MUDr. Pavel Fabián, Ph.D.; MUDr. Barbora Ondrová; MUDr. Peter Grell, Ph.D.; G. Jana; MUDr. Denis Princ; Mgr. Lenka Radová, Ph.D.; prof. MUDr. Pavel Šlampa, CSc.; prof. MUDr. Rostislav Vyzula, CSc.
Číslo abstraktu: 1026
Kategorie: Zhoubné nádory prsu

Metastatic male breast cancer (mMBC): Prognosis and survival of 35 patients

Autoři: R. Foerster; F. G. Foerster; D. Baaske; B. Schubotz; V. Wulff; C. Rudlowski
Číslo abstraktu: e12001
Kategorie: Zhoubné nádory prsu

Metastatic Lung Cancer

Final safety results of BO17704 (AVAiL): A phase III randomized study of first-line bevacizumab (Bv) and cisplatin/gemcitabine (CG) in patients (pts) with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)

Autoři: MD Vera Hirsh; Rodryg Ramlau; J. von Pawel; prof. MUDr. Petr Zatloukal (1955-2012), CSc.; G. Vera; N. B. Leighl; J. Mezger; Venice Archer; M. Reck
Číslo abstraktu: 8039
Kategorie: Zhoubné nádory plic a průdušek

Efficacy and safety of first-line bevacizumab (Bv) and cisplatin/gemcitabine (CG) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC) in the BO17704 study (AVAiL)

Autoři: N. B. Leighl; prof. MUDr. Petr Zatloukal (1955-2012), CSc.; J. Mezger; Rodryg Ramlau; Venice Archer; N. Moore; M. Reck
Číslo abstraktu: 8050
Kategorie: Zhoubné nádory plic a průdušek

Randomized phase II clinical trial comparing tremelimumab (CP-675,206) with best supportive care (BSC) following first-line platinum-based therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)

Autoři: prof. MUDr. Petr Zatloukal (1955-2012), CSc.; D. S. Heo; K. Park; J. Kang; Charles Andrew Butts; D. Bradford; S. Graziano; B. Huang; D. Healey
Číslo abstraktu: 8071
Kategorie: Zhoubné nádory plic a průdušek

Prostate Cancer

Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)

Autoři: F. Saad; M.D. Matthew Raymond Smith, Ph.D.; B. Egerdie; T. L. Tammela; R. A. Feldman; Doc. MUDr. Jiří Heráček, Ph.D.; M. Szwedowski; Ke C.; B. Leder; C. Goessl
Číslo abstraktu: 5056
Kategorie: Genitourinární nádory

Supportive Care

Therapy of palmar-plantar erythrodysesthesia after continual fluoropyrimidin administration with 10% uridin ointment

Autoři: PharmDr. Irena Netíková, Ph.D.; MUDr. Eva Sedláčková, MBA; doc. MUDr. Bohuslav Konopásek, CSc.; prof. MUDr. Luboš Petruželka, CSc.
Číslo abstraktu: e20690
Kategorie: Podpůrná onkologická léčba, výživa nemocných a ošetřovatelská péče